RSS   Newsletter   Contact   Advertise with us

C4X Discovery Holdings appoints two directors

Share on Twitter Share on LinkedIn
Staff Writer | Manchester, United Kingdom | July 5, 2018
C4X Discovery HoldingsC4X Discovery Holdings, a drug discovery company, announces that Eva-Lotta Allan and Natalie Walter have been appointed as non-executive chairman of the board and non-executive director respectively.
Eva-Lotta Allan has more than 30 years' experience in the healthcare industry.

During this time, she has been a Senior Executive and Board member at both public and private companies.

Most recently, Ms. Allan was Chief Business Officer and previously a Board member at Immunocore.

Prior to this, she served as Chief Business Officer and member of the Executive Committee and Euronext IPO team for Ablynx NV.

Ms. Allan also held senior positions at Vertex Pharmaceuticals (Europe) Ltd, Oxford Asymmetry International plc, Oxford Glycosciences (now part of UCB Celltech) and Amersham International (now part of GE Healthcare).

Ms. Allan currently serves as Non-Executive Director and Member of the Corporate Governance Committee and the R&D Sub-Committee of Targovax ASA and is a Non-Executive Director of Crescendo Biologics.

Until earlier this year, she was also a Board Member of the UK BioIndustry Association (BIA).

Natalie Walter is a corporate finance lawyer with more than 20 years of experience advising on international equity capital markets transactions in the healthcare sector.

Most recently, Ms. Walter was an Equity Partner at Covington & Burling LLP.

Prior to this, she had been an Equity Partner at Morrison & Foerster LLP and had spent part of her career as a Director and Legal Counsel on the ECM desk at Lehman Brothers.

Ms. Walter currently consults as General Counsel to Oxford BioMedica plc, having previously acted as external General Counsel to a number of companies and financial institutions, advising boards on a range of strategic, transactional and general corporate finance matters, with particular expertise in advising on deals in the life sciences and med tech sectors.

Ms. Walter also sits as a Non-Executive Director on the Board of RSA (Holdings) Ltd, a boutique talent consultancy in life sciences.

 LATEST MOVES FROM United Kingdom